SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3557 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3307" I do not like when Yan skip direct respond to Qs" What is this refeCuttingEdge Bio-6/10/2021
3306<Still a 15p/e on 30% plus growth is ridiculous.> Due to COVID 2Q growth wMiljenko Zuanic-6/9/2021
3305REGENERON ONCOLOGY INVESTOR EVENT, ASCO 2021 Highlights: Lag3, met/met +ADCBiotechwantabe-6/8/2021
3304Why invest in Regn mAbs when you can buy bntx mRna tech and make 8% per day. StBiotechwantabe-6/4/2021
3303I am surprised the stock hasn't dropped due to this news /sFelix B-6/4/2021
3302Under the agreement, the government will acquire doses at the lowest authorized Biotechwantabe-6/4/2021
3301FDA AUTHORIZES LOWER 1,200 MG INTRAVENOUS AND SUBCUTANEOUS DOSE OF REGEN-COV™ (CBiotechwantabe26/4/2021
3300I didn't realize Lily's cocktail was also ineffective against certain vaFelix B-6/1/2021
3299U.S. stops distributing Lilly's COVID-19 antibody therapy in six states, insBiotechwantabe15/28/2021
3298Interesting issue, barrons.com. REGN has a deal with the US government worth uA.J. Mullen-5/26/2021
3297It's probably above my payscale, but here goes: Phase I trials rarely move mA.J. Mullen-5/24/2021
3296So what are your thoughts on their abstract?Felix B-5/23/2021
3295Some SI people and some analysts pay a lot of attention to ASCO abstracts. A weA.J. Mullen-5/20/2021
3294investor.regeneron.com Probably best to review the last oncology event. It’Biotechwantabe-5/19/2021
3293I am not familiar with oncology - how meaningful is this?Felix B-5/19/2021
3292LIBTAYO® (CEMIPLIMAB-RWLC) PRESENTATIONS AT ASCO HIGHLIGHT EXPANDING CLINICBiotechwantabe-5/19/2021
3291Two encouraging reports of Regeneron trials in Medpage Today. Dupixent ImprovesA.J. Mullen-5/19/2021
3290REGN is horse that winn long race, not speedy one! hahaMiljenko Zuanic-5/6/2021
3289Eylea was much better than I expected. Was thinking below 8% Q1. Can’t wait foBiotechwantabe-5/6/2021
3288Eylea sale in US is OK! Growth continue! In EU as well. finance.yahoo.com PS: Miljenko Zuanic-5/6/2021
3287Lots of other biotech reporting fewer in office visits (Jan and feb) are hurtingBiotechwantabe-4/30/2021
3286Eylea US sale, and prosper for next few Q!Miljenko Zuanic-4/30/2021
3285Safety is important- eylea competitorBiotechwantabe-4/29/2021
3284Is there any upshot that REGN can report with Bayer and SNY reporting before theFelix B-4/29/2021
3283Dupi 1Q grow (per sanofi) only 8% 1Q/4Q, and in US is even less. They need to doMiljenko Zuanic-4/29/2021
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News